HIT: healthintech.com Forward P/S Multiple

Health In Tech Inc. - graphic logo of issuer HIT

Health In Tech Inc (HIT) automates underwriting via a fintech platform, developing software R&D for rapid quote calculation. The expected price-to-sales ratio helps assess the business's real value, where 0.90 expresses the current value of the metric. Ambitious management relies on data analysis to create efficient insurance products for small businesses.

HIT (Health In Tech) Forward Price to Sales history from 12/24/2024 to 11/13/2026

healthintech.com - analytical breakdowns and key metrics (HIT)

- stock price and consensus target price:
Stock Quotes Health In Tech|HIT - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Health In Tech|HIT - Value Adjusted for Debt and Cash
- issuer book value statistics:
Accounting Value per Share Health In Tech|HIT - Accounting Value of Company|Market Capitalization to Book Value Ratio healthintech.com|HIT - Company Total Asset Base
- debt and solvency information:
Debt to Equity Health In Tech Inc|HIT - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Health In Tech|HIT - Aggregate Debt Obligations|Debt to Book Value Health In Tech|HIT - Amount of Long-Term Liabilities|Company Short-Term Debts Health In Tech|Quick Ratio healthintech.com
- net income and valuation multiples indicators:
HIT - Net Income|Projected Future Earnings Health In Tech Inc|HIT - Company Value to Net Income|Projected Price to Earnings Health In Tech|HIT - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Health In Tech|HIT - Operating income before deduction of amortization|Earnings per share for the last twelve months Health In Tech|HIT - Earnings per share for the last 12 months|Quarterly EPS earnings growth healthintech.com|HIT - Net earnings per share growth this year|Earnings growth forecast for next year Health In Tech Inc
- company sales and revenue statistics:
HIT - Company Sales Revenue|Projected Sales Volume Health In Tech|HIT - Price-to-Revenue Coefficient|Forward Price-to-Revenue Multiple Health In Tech
Summary company analysis:Health In Tech, Inc. (HIT)
Original product of Health In Tech Inc.

To minimize investment risks, it is essential to assess the resilience of Health In Tech Inc. (HIT) capitalization against reductions in government subsidies and tax changes. Analyzing the Insurtech platform's ability to monetize medical plan administration through forward price-to-sales (P/S) ratio dynamics allows for the determination of the business's margin of safety. This indicator compares market value with expected revenues, identifying whether the asset is overbought or possesses growth potential when adapting to new fiscal conditions.

Competing companies

UnitedHealth - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio CI (Cigna Healthcare)|Aflac Insurance - Forward P/S Multiple|Forward Price to Sales HUM (Humana Corp)|CNC (Centene Corporation) - Forward Price-to-Revenue Multiple|molinahealthcare.com - Forward Price to Sales|MMS (Maximus) - Forward P/S Multiple|Oscar (OSCR) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Clover Health Corp (CLOV)|Claritev Health - Market Cap to Projected Revenue|Yuanbao Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales EHTH|GOCO: Forward Price-to-Revenue Multiple|NeueHealth, Inc. - Price to Expected Revenue Ratio|RELI: Forward P/S Multiple|Market Cap to Future Revenue Ratio MSP Recovery Corp (LIFW)|MPLN (MultiPlan Corporation) - Forward P/S Multiple